46 results on '"Andolfi, Grazia"'
Search Results
2. IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
3. Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases
4. Constitutive IL-1RA production by modified immune cells protects against IL-1–mediated inflammatory disorders
5. Aryl Hydrocarbon Receptor Activity is Required Downstream IL-10 Signaling to Promote Regulatory Functions in Human Dendritic Cells
6. Gene therapy for immunodeficiency due to adenosine deaminase deficiency
7. Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
8. Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy
9. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. (Reports)
10. Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells
11. Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
12. Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells
13. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement
14. IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
15. IL-10-Engineered Human CD4+Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
16. 637. Targeting of Myeloid Leukemia by IL-10-Engineered Human CD4+ Tr1 Cells
17. Transgenic expression of IL-10 by lentiviral vectors for increasing the anti-inflammatory efficacy of mesenchymal stromal cells
18. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells
19. Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4+ T Cells
20. IL-10-Engineered Human CD4+Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
21. Innate-Like Effector Differentiation of Human Invariant NKT Cells Driven by IL-7
22. Long-Term Safety and Efficacy of Stem Cell Gene Therapy for ADA-SCID.
23. Clonal Analyses of Retroviral Vector Integrations in ADA-SCID Patients Treated with Stem Cell Gene Therapy.
24. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells
25. Bone Marrow Clonogenic Capability, Cytokine Production, and Thymic Output in Patients with Common Variable Immunodeficiency
26. IL-3 or IL-7 Increases ex Vivo Gene Transfer Efficiency in ADA-SCID BM CD34+ Cells while Maintaining in Vivo Lymphoid Potential
27. X‐linked Opitz syndrome: Novel mutations in the MID1 gene and redefinition of the clinical spectrum
28. Identification of a New EGF-Repeat-Containing Gene from Human Xp22: A Candidate for Developmental Disorders
29. Identification of a Novel Homolog of the Drosophila staufen Protein in the Chromosome 8q13–q21.1 Region
30. Identification and Characterization of AFG3L2, a Novel Paraplegin-Related Gene
31. Identification of SCML2, a Second Human Gene Homologous to theDrosophila Sex comb on midleg(Scm): A New Gene Cluster on Xp22
32. Identification and Characterization of a Novel Serine– Threonine Kinase Gene from the Xp22 Region
33. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22
34. Identification by Shotgun Sequencing, Genomic Organization, and Functional Analysis of a Fourth Arylsulfatase Gene (ARSF) from the Xp22.3 Region
35. Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4+ T Cells.
36. MID2, a homologue of the Opitz syndrome gene MID1: similarities in subcellular localization and differences in expression during development.
37. Characterization of a Cluster of Sulfatase Genes on Xp22.3 Suggests Gene Duplications in an Ancestral Pseudoautosomal Region.
38. X-linked Opitz syndrome: Novel mutations in the <TOGGLE>MID1</TOGGLE> gene and redefinition of the clinical spectrum
39. Identification of a Novel Homolog of the Drosophila staufenProtein in the Chromosome 8q13–q21.1 Region
40. IL-3 or IL-7 Increases ex Vivo Gene Transfer Efficiency in ADA-SCID BM CD34+ Cells while Maintaining in Vivo Lymphoid Potential
41. IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism
42. MID2, a Homologue of the Opitz Syndrome Gene MID1: Similarities in Subcellular Localization and Differences in Expression During Development
43. Characterization of a cluster of sulfatase genes on Xp22.3 suggests gene duplications in an ancestral pseudoautosomal region
44. IL-10-Engineered Human CD4 + Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism.
45. Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells.
46. IL-10-Engineered Human CD4 + Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.